STOCK TITAN

Medicus Pharma: RBx Capital buys $750K in shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

Medicus Pharma Ltd. (MDCX) shares were acquired by RBx Capital, LP, an entity controlled by Dr. Raza Bokhari, in a private placement: 436,046 common shares on November 13, 2026, at $1.72 per share, for an aggregate purchase price of $749,999.12. The purchase was funded with RBx Capital’s working capital.

RBx Capital reported beneficial ownership of 451,909 shares, or 16.2%. Dr. Bokhari reported beneficial ownership of 538,233, or 19.1%, including shares held directly, through RBx Capital and underlying options. The reported percentages use 2,788,106 issued and outstanding shares as of November 16, 2026; Dr. Bokhari’s calculation also includes 27,500 option shares in the denominator.

Filing Explained

The amendment says RBx Capital acquired the shares for general investment purposes; the reporting persons report no current plans for the actions listed in Schedule 13D Item 4, but reserve the right to pursue them later.

Shares acquired 436,046 shares RBx Capital’s private placement purchase on November 13, 2026
Purchase price per share $1.72 Price for the private placement shares
Aggregate purchase price $749,999.12 RBx Capital’s private placement purchase
RBx Capital beneficial ownership 451,909 shares Reported beneficial ownership
RBx Capital ownership percentage 16.2% Calculated using 2,788,106 shares issued and outstanding as of November 16, 2026
Dr. Raza Bokhari beneficial ownership 538,233 shares Reported beneficial ownership, including shares held directly, through RBx Capital and underlying options
Dr. Raza Bokhari ownership percentage 19.1% Calculated using 2,788,106 shares issued and outstanding as of November 16, 2026, plus 27,500 option shares
Shares issued and outstanding 2,788,106 shares As of November 16, 2026
beneficially owned regulatory
"Aggregate amount beneficially owned by each reporting person"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
private placement financial
"in a private placement by the Issuer"
A private placement is a sale of securities directly to a selected group of investors, typically institutions or accredited investors, instead of through a public offering. It lets a company raise money faster and with fewer regulatory steps; for existing shareholders it matters because the newly issued shares, often sold at a discount, increase the share count and can dilute their ownership.
subscription agreement financial
"entered into a subscription agreement with the Issuer"
A subscription agreement is a legal contract in which an investor agrees to buy a specific number of a company’s shares or other securities under set terms, including price, payment method and conditions for closing the sale. It matters to investors because it legally locks in their purchase and the company’s obligations, determines ownership percentage and any investor rights, and can include conditions or promises that affect future control or returns—like signing a detailed purchase order for equity.
dispositive power regulatory
"Sole Dispositive Power"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.
pecuniary interest regulatory
"except to the extent of his pecuniary interest therein"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many MDCX shares did RBx Capital purchase, and at what price?

RBx Capital, LP acquired 436,046 Medicus Pharma common shares at $1.72 per share in the November 13, 2026 private placement, for an aggregate purchase price of $749,999.12.

How much of MDCX does Raza Bokhari beneficially own?

The cover page reports Dr. Raza Bokhari’s beneficial ownership as 538,233 common shares, or 19.1%. That percentage uses 2,788,106 issued and outstanding shares as of November 16, 2026, plus 27,500 shares underlying options held by Dr. Bokhari.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





58471K202

(CUSIP Number)
Dr. Raza Bokhari
300 Conshohocken State Road, Suite 200
West Conshohocken, PA, 19428
610-540-7515

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
11/13/2026

(Date of Event Which Requires Filing of This Statement)


If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D




Comment for Type of Reporting Person:
Includes (i) 27,500 common shares underlying stock options held by Dr. Raza Bokhari that are currently exercisable or will become exercisable within 60 days of the date hereof, (ii) 58,924 common shares held directly by Dr. Raza Bokhari and (iii) 451,909 common shares held by RBx Capital, LP, an entity controlled by Dr. Raza Bokhari (including the 436,046 common shares acquired by RBx Capital, LP in the Private Placement (as defined in Item 3)). Dr. Raza Bokhari may be deemed the beneficial owner of the securities held by RBx Capital, LP. Dr. Raza Bokhari disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.


SCHEDULE 13D






SCHEDULE 13D


BOKHARI, RAZA
Signature:/s/ Raza Bokhari
Name/Title:Dr. Raza Bokhari
Date:11/17/2026
RBx Capital, LP
Signature:/s/ Raza Bokhari
Name/Title:Dr. Raza Bokhari, Managing Partner
Date:11/17/2026

Keep reading